Mannan Antigen and Anti-Mannan Antibody
MA AMAB
Description
"Mannan Antigen and Anti-Mannan Antibody" test helps detect fungal infections like candidiasis by measuring a fungal component (mannan) and the immune response to it. Doctors often order this test for immunocompromised patients or those with unexplained fever and fatigue. Elevated mannan or antibody levels suggest active or recent fungal infection. The results guide antifungal treatment or further evaluation. Ongoing monitoring supports early detection and helps manage infections in people undergoing chemotherapy, organ transplant, or other immune-suppressing conditions.
Category
Antibodies
Procedure
Invasive
Sample Type
Blood – Serum
Units
Not Applicable
Procedure Category
Blood Draw
Test Group
Chronic Illness Group
Test Group Description
Chronic Illness Group: This group encompasses a range of tests specifically tailored to assess markers associated with chronic health conditions, providing comprehensive insights into the management and monitoring of chronic illnesses.
Optimal Range
For All Individuals:
Result: Negative: No abnormalities detected.
Normal Range
For All Individuals:
Result: Negative: No abnormalities detected.
Results That Differ From The Norm (Direct and Indirect Causes)
Abnormal results may indicate:
Candidemia (Presence of Candida fungi in the bloodstream)
Chronic mucocutaneous candidiasis (Persistent fungal infection of the mucous membranes and skin)
Intra-abdominal candidiasis (Candida infection within the abdomen)
Invasive candidiasis (Systemic infection caused by Candida fungi)
Key Reasons For Testing
Diagnosis of Invasive Candidiasis: Detects Candida infections in immunocompromised patients or those with bloodstream infections.
Identification of Candida Species: Differentiates Candida albicans from non-albicans species for targeted treatment.
Monitoring Response to Antifungal Therapy: Tracks mannan antigen levels to assess treatment effectiveness.
Detection of Fungal Infections in Immunocompromised Patients: Identifies fungal complications in high-risk groups.
Differentiation of Fungal and Bacterial Infections: Helps distinguish candidiasis from bacterial infections for appropriate therapy.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis. 2005;40(12):1762-1769.
[2] Sendid B, Poirot JL, Tabouret M, et al. Combined detection of mannanaemia and anti-mannan antibodies as a strategy for the diagnosis of systemic infection caused by Candida species. J Med Microbiol. 2002;51(5):433-442.
[3] Stynen D, Sarfati J, Goris A, et al. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun. 1992;60(6):2237-2245.
[4] Pini P, Debbia EA, Cruciani M, Danese S, Bonvicini F, Bernardi E. Anti-mannan antibodies in patients with candidemia: correlation with clinical outcomes. Mycoses. 2010;53(4):322-330.
[5] Nguyen MH, Clancy CJ, Yu VL, Yu YC. Do Mannan antigen and anti-mannan antibody tests have roles in the diagnosis and management of invasive candidiasis? Clin Infect Dis. 1995;21(6):1325-1327.
[6] Adam O, Stynen D, Madesclaire M, Quet W, Morel AM, Kuchler A. Serum galactomannan and anti-mannan antibodies: value for diagnosis of invasive aspergillosis in neutropenic patients. J Infect. 2004;49(2):141-144.
[7] Herbrecht R, Patterson TF, Slavin MA, et al. Application of the galactomannan enzyme immunoassay in the diagnosis of invasive aspergillosis. Clin Infect Dis. 2002;34(5):671-677.
[8] Sanguinetti M, Posteraro B, La Sorda M, et al. Role of serum Candida antigen and anti-Candida antibody in the laboratory diagnosis of candidemia. Eur J Clin Microbiol Infect Dis. 2004;23(9):666-668.
[9] Gubbins PO, Krishna G, Sansone-Parsons A, Penzak SR, Anaissie EJ. Pharmacokinetics of posaconazole in neutropenic stem cell transplant recipients. Antimicrob Agents Chemother. 2006;50(6):1993-1999.
[10] Holt RJ, Youngs ER, Ghosh S. Significance of the anti-mannan antibody test for candidiasis in immunocompromised hosts. Mycoses. 1990;33(6):299-302.
[11] Odabasi Z, Mattiuzzi G, Estey E, et al. Candida mannan antigen detection in the diagnosis of invasive candidiasis. Clin Infect Dis. 2004;39(8):1100-1107.
[12] Johnson MD, Drew RH, Perfect JR. A prospective study of the epidemiology of candidemia and the risk factors for mortality among hospitalized patients. Clin Infect Dis. 2001;33(12):1875-1881.
[13] Marty FM, Koo S. Role of (1→3)-β-D-glucan in the diagnosis and management of invasive fungal infections. Clin Infect Dis. 2009;48(6):732-740.
[14] Clancy CJ, Nguyen MH. Finding the "missing 50%" of invasive candidiasis: how non-culture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013;56(9):1284-1292.